Sterilization methods for medical devices

US9682162B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9682162-B2
Application numberUS-201414153477-A
CountryUS
Kind codeB2
Filing dateJan 13, 2014
Priority dateAug 15, 2006
Publication dateJun 20, 2017
Grant dateJun 20, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Methods of sterilizing medical devices, including implantable medical devices like stents, chemically and with radiation are disclosed. Methods of preparing a sterile, packaged medical device, including a sterile, packaged implantable medical device or stent are disclosed.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for preparing a sterilized packaged stent, the method comprising: exposing a stent comprising a polymer to radiation to sterilize the stent while the stent is in an uncrimped state; after exposing the stent to radiation to sterilize the stent, coating the stent aseptically; and packaging the coated stent to form the sterilized packaged stent. 2. The method of claim 1 , wherein the stent is exposed to radiation to sterilize the stent prior to mounting the stent on a delivery device. 3. The method of claim 1 , further comprising mounting the coated stent onto a delivery device. 4. The method of claim 1 , further comprising performing one or more additional stent processing operations, wherein all of the one or more stent processing operations subsequent to the exposure of the stent to radiation to sterilize the stent are performed aseptically. 5. The method of claim 1 , wherein the sterilization is electron beam sterilization. 6. The method of claim 1 , wherein the polymer is selected from the group consisting of poly(N-acetylglucosamine) (Chitin), Chitosan, poly(3-hydroxyvalerate), poly(lactide-co-glycolide), poly(-hydroxybutyrate), poly(-hydroxybutyrate), poly(3-hydroxybutyrate-co-3-hydroxyvalerate), polyorthoesters, polyanhydrides, poly(glycolic acid), poly(glycolide), poly(L-lactic acid), poly(L-lactide), poly(D,L-lactic acid), poly(D,L-lactide), poly(L-lactide-co-D,L-lactide), poly(caprolactone), poly(L-lactide-co-caprolactone), poly(D,L-lactide-co-caprolactone), poly(glycolide-co-caprolactone), poly(trimethylene carbonate), polyester amides, poly(glycolic acid-co-trimethylene carbonate), co-poly(ether-esters) (e.g. PEO/PLA), polyphosphazenes, fibrin, fibrinogen, cellulose, starch, collagen, hyaluronic acid, polyurethanes, silicones, polyesters, polyolefins, polyisobutylene and ethylene-alphaolefin copolymers, acrylic polymers and copolymers, vinyl halide polymers and copolymers, polyvinyl chloride, polyvinyl ethers, polyvinyl methyl ether, polyvinylidene halides, polyvinylidene chloride, polyacrylonitrile, polyvinyl ketones, polyvinyl aromatics, polystyrene, polyvinyl esters, acrylonitrile-styrene copolymers, acrylonitrile butadiene styrene resins, polyamides, Nylon 66, polycaprolactam, polycarbonates, polyoxymethylenes, polyimides, polyethers, rayon, rayon-triacetate, cellulose acetate, cellulose butyrate, cellulose acetate butyrate, cellophane, cellulose nitrate, cellulose propionate, cellulose ethers, carboxymethyl cellulose, ethylene vinyl alcohol copolymer, poly(butyl methacrylate), poly(vinylidene fluoride-co-hexafluoropropene), polyvinylidene fluoride, ethylene-vinyl acetate copolymers, poly(vinyl acetate), styrene-isobutylene-styrene triblock copolymers, polyethylene glycol, and combinations thereof. 7. The method of claim 1 , wherein the stent further comprises a drug. 8. The method of claim 1 , wherein the stent further comprises a bioactive agent. 9. The method of claim 1 , wherein the stent further comprises a protein. 10. The method of claim 1 , wherein the stent further comprises a macromolecule.

Assignees

Inventors

Classifications

  • Containers other than laboratory or medical, e.g. bottles or mail · CPC title

  • Laboratory, medical or dentistry appliances, e.g. catheters or sharps · CPC title

  • Packages or dispensers for prostheses or other implants (for intraocular lenses A61F2/1691; for dental surgery A61C19/02) · CPC title

  • Human Necessities · mapped topic

  • A61L2/08Primary

    Radiation · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9682162B2 cover?
Methods of sterilizing medical devices, including implantable medical devices like stents, chemically and with radiation are disclosed. Methods of preparing a sterile, packaged medical device, including a sterile, packaged implantable medical device or stent are disclosed.
Who is the assignee on this patent?
Abbott Cardiovascular Systems Inc
What technology area does this patent fall under?
Primary CPC classification A61L2/08. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jun 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).